RxDoctor Payments Data

Jill Yeager, DO

Hematology & Oncology · East Syracuse, NYNPI 1871977041

Payments from drug & device makers

What this record shows

This record is dominated by education: $20 of the $20 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, AVEO Pharmaceuticals, Inc.. That places this record below the midpoint for hematology & oncology clinicians in NY, where the typical reported total is $1,337.

$20in general payments, 2019–2025

Across 1 payment — averaging $20.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AVEO Pharmaceuticals, Inc.$20
$26,500in research payments, 2019–2025

Across 2 payments — averaging $13,250 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AstraZeneca$27K

What the payments were for

  • Education$20100%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AVEO Pharmaceuticals, Inc.1$20

How this compares

$20 in reported general payments places this provider in the 0th percentile of 967 hematology & oncology providers in New York.

See all hematology & oncology providers in New York →

Medicare billing

Part B allowed, 2024
$2,541,429
Medicare patients
840
Services billed
108,580

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
KisqaliRibociclib Succinate13$182,561
VerzenioAbemaciclib12$174,650
EliquisApixaban19$19,041
XareltoRivaroxaban19$12,384
Anastrozole163$2,080
Tamoxifen Citrate66$1,385
Letrozole48$740
Hydroxyurea37$632
Nystatin14$338

Paid to pharmacies, not to this prescriber.

Other hematology & oncology in East Syracuse

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →